Advertisement |  | Accurately predict Cas9 and sgRNA binding in your CRISPR experiments
Diagenode's iDeal ChIP-seq Kit for Transcription Factors:
- Latest method of choice to verify sgRNA specificity
- Uses robust ChIP method followed by qPCR to verify enrichment of dCas9 at expected target
- Sequencing analysis of the immunoprecipitated DNA shows off-target effects genome-wide
Learn more and read the new application note. | | | |  |  | TABLE OF CONTENTS | |  | | Volume 37, Issue 24 |  | In this issue Review Article Article Also new AOP
| |  |  |  | Review Article | | | Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations Matthew Dankner, April A. N. Rose, Shivshankari Rajkumar, Peter M. Siegel & Ian R. Watson Oncogene 2018 37 :3183 - 3199; March 15, 2018; 10.1038/s41388-018-0171-x Abstract | Full Text |  |  |  |  | The multiple paths towards MET receptor addiction in cancer Leslie Duplaquet, Zoulika Kherrouche, Simon Baldacci, Philippe Jamme, Alexis B. Cortot et al. Oncogene 2018 37 :3200 - 3215; March 19, 2018; 10.1038/s41388-018-0185-4 Abstract | Full Text |  | Article | | | Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer Vikash Reebye, Kai-Wen Huang, Vivian Lin, Sheba Jarvis, Pedro Cutilas et al. Oncogene 2018 37 :3216 - 3228; March 07, 2018; 10.1038/s41388-018-0126-2 Abstract | Full Text |  |  |  |  | Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice Jingxiao Wang, Mingjie Dong, Zhong Xu, Xinhua Song, Shanshan Zhang et al. Oncogene 2018 37 :3229 - 3242; March 16, 2018; 10.1038/s41388-018-0188-1 Abstract | Full Text |  |  |  |  | LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer S. Wang, Z. Zou, X. Luo, Y. Mi, H. Chang et al. Oncogene 2018 37 :3243 - 3259; March 16, 2018; 10.1038/s41388-018-0193-4 Abstract | Full Text |  |  |  |  | Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition Chao Shi, Bei-Qing Pan, Feng Shi, Zhi-Hui Xie, Yan-Yi Jiang et al. Oncogene 2018 37 :3260 - 3274; March 19, 2018; 10.1038/s41388-018-0217-0 Abstract | Full Text |  |  |  |  | AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma Qiang Zuo, Jing Liu, Liping Huang, Yifei Qin, Teresa Hawley et al. Oncogene 2018 37 :3275 - 3289; March 19, 2018; 10.1038/s41388-018-0205-4 Abstract | Full Text |  |  |  |  | Thyroid transcription factor 1 enhances cellular statin sensitivity via perturbing cholesterol metabolism Shao-Chiang Lai, Cody A. Phelps, Aleena M. Short, Sucharita M. Dutta & David Mu Oncogene 2018 37 :3290 - 3300; March 19, 2018; 10.1038/s41388-018-0174-7 Abstract | Full Text |  |  |  |  | ß-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy Concetta Saponaro, Sara Sergio, Antonio Coluccia, Maria De Luca, Giuseppe La Regina et al. Oncogene 2018 37 :3301 - 3316; March 19, 2018; 10.1038/s41388-018-0170-y Abstract | Full Text |  |  |  |  | Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation Ki-Chun Yoo, Yongjoon Suh, Yoojeong An, Hae-June Lee, Ye Ji Jeong et al. Oncogene 2018 37 :3317 - 3328; March 21, 2018; 10.1038/s41388-018-0199-y Abstract | Full Text |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. |  | | |
No comments:
Post a Comment